|2.88|| +0.10 / +3.60%|
Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA.
|Gary J. G. Atkinson||CEO, CFO, Secretary & Senior VP|
|Roger Allen Sabbadini||Vice President|
|Leigh Hsu||Vice President-Corporate Development & Strategy|